Enzon Pharmaceuticals
Country
USA
Краткое название
Enzon Pharmaceuticals
Headquarters
20 Kingsbridge Road
Members of the board
George W. Hebard III, M.B.A.,
Interim Principal Executive Officer and Chief Operating Officer
Charles Conover, Ph.D., M.B.A.,
Senior Vice President, Research and Development, Program Management
Andrew Rackear, J.D.,
Vice President and General Counsel
Timothy G. Daly,
Vice President, Controller and Chief Accounting Officer
Categories medicine
Therapy
Stage of the project
Production
Disease
Anemia
Ticker
ENZN
Current owners
Alexander J. Denner, Ph.D.,
Chairman
Richard C. Mulligan, Ph.D.,
Vice-Chairman
Thomas F. Deuel, M.D.
George W. Hebard III, M.B.A.
Robert LeBuhn, M.B.A.
Robert C. Salisbury, M.B.A.
Richard A. Young, Ph.D.
Assets
53.9000
Technology
Devices, Technologies, Pharmaceuticals, Chemistry